About

Pioneering Excellence,
Where Quality Meets Value

Selatox is a biotechnology company dedicated to developing and manufacturing innovative aesthetic solutions, combining scientific expertise, precision manufacturing, and global quality standards.

Scroll to explore ↓
01
Vision

Advancing Beauty Through Science

To become a globally trusted biotechnology company that transforms aesthetic medicine through innovation, quality, and scientific excellence.

02
Mission

Delivering Innovative Solutions for Global Aesthetic Healthcare

We develop and manufacture high-quality aesthetic therapies through advanced biotechnology and pharmaceutical-grade manufacturing, creating lasting value for patients, healthcare professionals, and partners worldwide.

  • Core Values

    Our Shared Principles

    Five commitments that guide every decision, partnership, and long-term move at Selatox.

  • Excellence

    We pursue excellence in every process, product, and decision to achieve the highest standards of quality and reliability.

  • Innovation

    We challenge conventions and embrace innovation to advance science and create meaningful solutions.

  • Integrity

    We act with transparency, ethics, and accountability in everything we do.

  • Partnership

    We build long-term partnerships based on trust, respect, and shared success.

Leadership

At Selatox, our commitment goes beyond manufacturing;

it is about establishing a sustainable, world-class bio-ecosystem in Indonesia.

Through strategic partnerships, rigorous talent discovery, and an unwavering adherence to quality, we are not just entering the global market—we are preparing to lead it.

Joh YounghoonChief Executive Officer
  1. 01 — Where we started

    Company History

  2. 2023

    Establishment of Selatox

    SeptemberEstablishment of PT. Selatox Bio Pharma
    Establishment of Selatox
  3. 2024

    Completion of the Cikarang Manufacturing Facility

    MarchPile construction
    AprilMain construction
    DecemberConstruction completion (SLF application)
    Completion of the Cikarang Manufacturing Facility
  4. 2025

    Execution of Global Botulinum Toxin Technology Transfer Agreement

    NovemberTechnology development contract
    Execution of Global Botulinum Toxin Technology Transfer Agreement
  5. 2026

    GMP Approval

    GMP certification and Expert approval
    R&D center establishment
    Current Phase
    GMP Approval
  6. 02 — Where we're headed

    Milestones

  7. 2028

    Domestic Launch

    Product registration (Indonesia)
    Partnering with +40 countries
    Domestic Launch
  8. 2030

    Global Scaling

    Global Launching and commercialization
    Vision 2030
    Global Scaling

Get in Touch

Business & General Inquiries

contact@selatox.com

Public Relations

pr@selatox.com

Ethics & Compliance

compliance@selatox.com